Comerica Bank
RVMD icon

Comerica Bank’s Revolution Medicines RVMD Stock Holding History

Comerica Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.85M Sell
23,285
-466,931
-95% -$30.6M 0.01% 1157
2025
Q3 		$22.9M Buy
490,216
+205,257
+72% +$8.04M 0.09% 224
2025
Q2 		$10.5M Buy
284,959
+91,240
+47% +$3.51M 0.04% 407
2025
Q1 		$6.85M Buy
193,719
+193,267
+42,758% +$7.84M 0.03% 530
2024
Q4 		$19.8K Sell
452
-7
-2% -$353 ﹤0.01% 3032
2024
Q3 		$20.9K Buy
459
+142
+45% +$6.18K ﹤0.01% 3028
2024
Q2 		$12.3K Sell
317
-246
-44% -$9.2K ﹤0.01% 3118
2024
Q1 		$18.2K Buy
+563
New +$16.7K ﹤0.01% 3051

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Comerica Bank's RVMD Position: Q4 2025 in Review

Comerica Bank reduced its Revolution Medicines (RVMD) stake by 95% in Q4 2025, selling an estimated $30.6M and leaving 23,285 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #1157.

Comerica Bank first reported a position in RVMD in Q1 2024 and has held it in 8 quarters since. The position peaked at $22.9M in Q3 2025. 386 funds tracked by Wall St. Rank hold RVMD as of Q4 2025.

  • Comerica Bank held 23,285 shares of Revolution Medicines worth $1.85M as of Q4 2025.
  • Comerica Bank sold 466,931 Revolution Medicines shares in Q4 2025, an estimated $30.6M.
  • Revolution Medicines made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1157 holding.
  • Comerica Bank first reported a position in Revolution Medicines in Q1 2024 and has held it in 8 quarters since.
  • Comerica Bank's Revolution Medicines position peaked at $22.9M in Q3 2025.
  • 386 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.